
HRT and the FDA
The Brian Lehrer Show
00:00
Intro
This chapter examines the FDA's recent proposal to eliminate warning labels from hormone therapy products for menopause. A physician provides insights into menopause, its symptoms, and the potential impact of this decision on patients and healthcare providers.
Transcript
Play full episode